4/17
07:29 am
cstl
We're Not Worried About Castle Biosciences' (NASDAQ:CSTL) Cash Burn [Yahoo! Finance]
Medium
Report
We're Not Worried About Castle Biosciences' (NASDAQ:CSTL) Cash Burn [Yahoo! Finance]
4/11
07:06 am
cstl
Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024 [Yahoo! Finance]
Low
Report
Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024 [Yahoo! Finance]
4/11
07:00 am
cstl
Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024
Low
Report
Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024
4/10
05:10 pm
cstl
Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations [Yahoo! Finance]
Low
Report
Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations [Yahoo! Finance]
4/10
05:00 pm
cstl
Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations
Low
Report
Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations
4/10
07:05 am
cstl
Castle Biosciences' Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year [Yahoo! Finance]
Medium
Report
Castle Biosciences' Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year [Yahoo! Finance]
4/10
07:00 am
cstl
Castle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year
Medium
Report
Castle Biosciences’ Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year
4/5
04:54 am
cstl
What Makes Castle Bioscience (CSTL) a Prospective Investment? [Yahoo! Finance]
Low
Report
What Makes Castle Bioscience (CSTL) a Prospective Investment? [Yahoo! Finance]
4/4
04:45 pm
cstl
Presentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx®-Melanoma and DecisionDx®-SCC Tests on the Management of Patients with Skin Cancer [Yahoo! Finance]
Low
Report
Presentations at EADO Highlight Potential Impact of Castle Biosciences' DecisionDx®-Melanoma and DecisionDx®-SCC Tests on the Management of Patients with Skin Cancer [Yahoo! Finance]
4/4
04:30 pm
cstl
Presentations at EADO Highlight Potential Impact of Castle Biosciences’ DecisionDx®-Melanoma and DecisionDx®-SCC Tests on the Management of Patients with Skin Cancer
Low
Report
Presentations at EADO Highlight Potential Impact of Castle Biosciences’ DecisionDx®-Melanoma and DecisionDx®-SCC Tests on the Management of Patients with Skin Cancer
4/2
07:00 am
cstl
Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
Low
Report
Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
3/27
05:14 pm
cstl
Castle Biosciences Announces Updates to its Board of Directors [Yahoo! Finance]
Medium
Report
Castle Biosciences Announces Updates to its Board of Directors [Yahoo! Finance]
3/27
05:00 pm
cstl
Castle Biosciences Announces Updates to its Board of Directors
Medium
Report
Castle Biosciences Announces Updates to its Board of Directors
3/25
07:05 am
cstl
Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year [Yahoo! Finance]
Low
Report
Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year [Yahoo! Finance]
3/25
07:00 am
cstl
Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year
Low
Report
Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year
3/22
04:50 pm
cstl
Long-term Outcomes Data Shared at SSO 2024 Show That Patients with a Low-Risk DecisionDx®-Melanoma Test Result Were Recurrence Free at Three Years, Including Those Who Utilized the Test to Help Guide the Decision to Avoid an SLNB [Yahoo! Finance]
Low
Report
Long-term Outcomes Data Shared at SSO 2024 Show That Patients with a Low-Risk DecisionDx®-Melanoma Test Result Were Recurrence Free at Three Years, Including Those Who Utilized the Test to Help Guide the Decision to Avoid an SLNB [Yahoo! Finance]
3/22
04:30 pm
cstl
Long-term Outcomes Data Shared at SSO 2024 Show That Patients with a Low-Risk DecisionDx®-Melanoma Test Result Were Recurrence Free at Three Years, Including Those Who Utilized the Test to Help Guide the Decision to Avoid an SLNB
Low
Report
Long-term Outcomes Data Shared at SSO 2024 Show That Patients with a Low-Risk DecisionDx®-Melanoma Test Result Were Recurrence Free at Three Years, Including Those Who Utilized the Test to Help Guide the Decision to Avoid an SLNB
3/20
05:31 am
cstl
Does Castle Bioscience (CSTL) Have Robust Growth Prospects? [Yahoo! Finance]
Medium
Report
Does Castle Bioscience (CSTL) Have Robust Growth Prospects? [Yahoo! Finance]
3/19
07:06 am
cstl
Leading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx®-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation Therapy [Yahoo! Finance]
Low
Report
Leading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx®-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation Therapy [Yahoo! Finance]
3/19
07:00 am
cstl
Leading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx®-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation Therapy
Low
Report
Leading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx®-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation Therapy
3/15
04:41 pm
cstl
New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences' IDgenetix® Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Alone for Patients 65 and Older [Yahoo! Finance]
Medium
Report
New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences' IDgenetix® Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Alone for Patients 65 and Older [Yahoo! Finance]
3/15
04:30 pm
cstl
New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences’ IDgenetix® Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Alone for Patients 65 and Older
Medium
Report
New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences’ IDgenetix® Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Alone for Patients 65 and Older
3/12
07:17 am
cstl
Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum [Yahoo! Finance]
Low
Report
Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum [Yahoo! Finance]
3/12
07:00 am
cstl
Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
Low
Report
Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
3/8
04:40 pm
cstl
Castle Biosciences to Present New Data Highlighting the Clinical Value of its Dermatologic Tests for Patients with Skin Cancer at the 2024 American Academy of Dermatology (AAD) Annual Meeting [Yahoo! Finance]
Medium
Report
Castle Biosciences to Present New Data Highlighting the Clinical Value of its Dermatologic Tests for Patients with Skin Cancer at the 2024 American Academy of Dermatology (AAD) Annual Meeting [Yahoo! Finance]